TransMedics Group, Inc. Earnings Per Share (Basic)
TransMedics Group, Inc. (TMDX) reported Earnings Per Share (Basic) of $0.42 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-04
- TransMedics Group, Inc. earnings per share, basic for the quarter ending 2026-06-30 was $0.42, a 59.22% decline year-over-year.
- TransMedics Group, Inc. earnings per share, basic for the quarter ending 2026-03-31 was $0.21, a 72.37% decline year-over-year.
- TransMedics Group, Inc. earnings per share, basic for the quarter ending 2025-12-31 was $3.08, a 1400.92% increase year-over-year.
- TransMedics Group, Inc. earnings per share, basic for the quarter ending 2025-09-30 was $0.71, a 446.15% increase year-over-year.
- TransMedics Group, Inc. earnings per share, basic for fiscal 2025 was $5.60, a 423.36% increase from fiscal 2024.
- TransMedics Group, Inc. earnings per share, basic for fiscal 2024 was $1.07.
- TransMedics Group, Inc. earnings per share, basic for fiscal 2023 was -$0.77.
- TransMedics Group, Inc. earnings per share, basic for fiscal 2022 was -$1.23.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.42 10-Q · filed 2026-08-04 | $0.64 10-Q · filed 2026-08-04 | $3.70 derived: net income ÷ weighted average shares · filed 2026-08-04 | $4.42 derived: net income ÷ weighted average shares · filed 2026-08-04 |
| 2026-03-31 | $0.21 10-Q · filed 2026-05-05 | $3.29 derived: net income ÷ weighted average shares · filed 2026-08-04 | $4.00 derived: net income ÷ weighted average shares · filed 2026-08-04 | $5.03 derived: net income ÷ weighted average shares · filed 2026-08-04 |
| 2025-12-31 | $3.08 derived: net income ÷ weighted average shares · filed 2026-04-10 | $3.80 derived: net income ÷ weighted average shares · filed 2026-04-10 | $4.83 derived: net income ÷ weighted average shares · filed 2026-08-04 | $5.60 10-K · filed 2026-02-24 |
| 2025-09-30 | $0.71 10-Q · filed 2025-10-29 | $1.74 derived: net income ÷ weighted average shares · filed 2026-08-04 | $2.50 10-Q · filed 2025-10-29 | $2.71 derived: net income ÷ weighted average shares · filed 2026-08-04 |
| 2025-06-30 | $1.03 10-Q · filed 2026-08-04 | $1.79 10-Q · filed 2026-08-04 | $2.00 derived: net income ÷ weighted average shares · filed 2026-08-04 | $2.13 derived: net income ÷ weighted average shares · filed 2026-08-04 |
| 2025-03-31 | $0.76 10-Q · filed 2026-05-05 | $0.97 derived: net income ÷ weighted average shares · filed 2026-08-04 | $1.10 derived: net income ÷ weighted average shares · filed 2026-08-04 | $1.46 derived: net income ÷ weighted average shares · filed 2026-08-04 |
| 2024-12-31 | $0.21 derived: net income ÷ weighted average shares · filed 2026-04-10 | $0.33 derived: net income ÷ weighted average shares · filed 2026-04-10 | $0.70 derived: net income ÷ weighted average shares · filed 2026-04-10 | $1.07 10-K · filed 2026-02-24 |
| 2024-09-30 | $0.13 10-Q · filed 2025-10-29 | $0.49 derived: net income ÷ weighted average shares · filed 2025-10-29 | $0.86 10-Q · filed 2025-10-29 | $0.99 derived: net income ÷ weighted average shares · filed 2026-04-10 |
| 2024-06-30 | $0.37 10-Q · filed 2025-07-30 | $0.74 10-Q · filed 2025-07-30 | $0.87 derived: net income ÷ weighted average shares · filed 2026-04-10 | $0.09 derived: net income ÷ weighted average shares · filed 2026-04-10 |
| 2024-03-31 | $0.37 10-Q · filed 2025-05-08 | $0.50 derived: net income ÷ weighted average shares · filed 2026-04-10 | -$0.28 derived: net income ÷ weighted average shares · filed 2026-04-10 | -$0.31 derived: net income ÷ weighted average shares · filed 2026-04-10 |
| 2023-12-31 | $0.12 derived: net income ÷ weighted average shares · filed 2026-04-10 | -$0.65 derived: net income ÷ weighted average shares · filed 2026-04-10 | -$0.69 derived: net income ÷ weighted average shares · filed 2026-04-10 | -$0.77 10-K · filed 2026-02-24 |
| 2023-09-30 | -$0.78 10-Q · filed 2024-10-29 | -$0.81 derived: net income ÷ weighted average shares · filed 2024-10-29 | -$0.89 10-Q · filed 2024-10-29 | -$1.10 derived: net income ÷ weighted average shares · filed 2026-04-10 |
| 2023-06-30 | -$0.03 10-Q · filed 2024-08-01 | -$0.11 10-Q · filed 2024-08-01 | -$0.32 derived: net income ÷ weighted average shares · filed 2026-04-10 | -$0.56 derived: net income ÷ weighted average shares · filed 2026-04-10 |
| 2023-03-31 | -$0.08 10-Q · filed 2024-05-02 | -$0.29 derived: net income ÷ weighted average shares · filed 2026-04-10 | -$0.53 derived: net income ÷ weighted average shares · filed 2026-04-10 | -$0.92 derived: net income ÷ weighted average shares · filed 2026-04-10 |
| 2022-12-31 | -$0.21 derived: net income ÷ weighted average shares · filed 2026-04-10 | -$0.45 derived: net income ÷ weighted average shares · filed 2026-04-10 | -$0.85 derived: net income ÷ weighted average shares · filed 2026-04-10 | -$1.23 10-K · filed 2025-02-27 |
| 2022-09-30 | -$0.25 10-Q · filed 2023-11-08 | -$0.65 derived: net income ÷ weighted average shares · filed 2023-11-08 | -$1.03 10-Q · filed 2023-11-08 | -$1.48 derived: net income ÷ weighted average shares · filed 2026-04-10 |
| 2022-06-30 | -$0.41 10-Q · filed 2023-08-04 | -$0.79 10-Q · filed 2023-08-04 | -$1.24 derived: net income ÷ weighted average shares · filed 2026-04-10 | -$1.71 derived: net income ÷ weighted average shares · filed 2026-04-10 |
| 2022-03-31 | -$0.38 10-Q · filed 2023-05-04 | -$0.83 derived: net income ÷ weighted average shares · filed 2026-04-10 | -$1.30 derived: net income ÷ weighted average shares · filed 2026-04-10 | -$1.69 derived: net income ÷ weighted average shares · filed 2026-04-10 |
| 2021-12-31 | -$0.46 derived: net income ÷ weighted average shares · filed 2026-04-10 | -$0.92 derived: net income ÷ weighted average shares · filed 2026-04-10 | -$1.31 derived: net income ÷ weighted average shares · filed 2026-04-10 | -$1.60 10-K · filed 2024-02-27 |
| 2021-09-30 | -$0.47 10-Q · filed 2022-11-04 | -$0.85 derived: net income ÷ weighted average shares · filed 2022-11-04 | -$1.14 10-Q · filed 2022-11-04 | -$1.38 derived: net income ÷ weighted average shares · filed 2023-02-27 |
| 2021-06-30 | -$0.39 10-Q · filed 2022-08-03 | -$0.68 10-Q · filed 2022-08-03 | -$0.91 derived: net income ÷ weighted average shares · filed 2023-02-27 | -$1.10 derived: net income ÷ weighted average shares · filed 2023-02-27 |
| 2021-03-31 | -$0.29 10-Q · filed 2022-05-05 | -$0.52 derived: net income ÷ weighted average shares · filed 2023-02-27 | -$0.71 derived: net income ÷ weighted average shares · filed 2023-02-27 | -$1.06 derived: net income ÷ weighted average shares · filed 2023-02-27 |
| 2020-12-31 | -$0.23 derived: net income ÷ weighted average shares · filed 2023-02-27 | -$0.42 derived: net income ÷ weighted average shares · filed 2023-02-27 | -$0.77 derived: net income ÷ weighted average shares · filed 2023-02-27 | -$1.16 10-K · filed 2023-02-27 |
| 2020-09-30 | -$0.19 10-Q · filed 2021-11-09 | -$0.54 derived: net income ÷ weighted average shares · filed 2021-11-09 | -$0.94 10-Q · filed 2021-11-09 | |
| 2020-06-30 | -$0.36 10-Q · filed 2021-08-06 | -$0.78 10-Q · filed 2021-08-06 | ||
| 2020-03-31 | -$0.42 10-Q · filed 2021-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |